Small molecule · Inhibitor of voltage-gated sodium channel (neuronal membrane) · developed by Pacira Pharms
Liposomal bupivacaine is a liposome-encapsulated formulation of bupivacaine, an amide-type long-acting local anesthetic. Bupivacaine reversibly binds sodium ion channels in the neuronal membrane, inhibiting depolarization and nerve impulse conduction, and liposomal delivery prolongs the duration of action. It is studied in postoperative pain, total knee arthroplasty, rotator cuff tear, hand and wrist injuries, and bunionectomy.
Summary written with AI from the sources listed at the end of this page.
From the indications section of the FDA label (version of Dec 12, 2025). Read the full label for the exact wording, limitations and safety information.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT07584915 | Phase 4 | Total Knee Arthroplasty | Enrolling by invitation | PCRX |
| NCT05730920 | Phase 4 | Adolescent Idiopathic Scoliosis | Completed | PCRX |
| NCT04102267 | Phase 4 | Analgesia | Completed | HRTX |
| NCT03290196 | Phase 4 | Rotator Cuff Tear | Terminated | PCRX |
| NCT02058303 | Phase 4 | Hand Injuries | Terminated | PCRX |
| NCT06077422 | Phase 2/3 | Pain, Postoperative | Enrolling by invitation | PCRX |
| NCT05157841 | Phase 3 | Bunionectomy | Completed | PCRX |
| NCT04117074 | Phase 3 | Surgery | Completed | PCRX |
| NCT05456490 | Phase 1 | Healthy | Completed | PCRX |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Heart DiseasesOpioid UsePain, PostoperativePerioperative ComplicationTotal Knee ArthroplastyTotal Knee Arthroplasty RecoveryAdolescent Idiopathic ScoliosisAnalgesiaBunionectomyFinger InjuriesHallux ValgusHand InjuriesHealthyJuvenile Idiopathic Scoliosis
Updated Oct 25, 2026. Something wrong or missing? Report it on the PCRX page.
See PCRX's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
PCRX catalysts and pipeline →